Real-world effectiveness of ribociclib + aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: The RIBANNA study
Fasching, P.A., Decker, T., Guderian, G., Heim, J., Jackisch, C., Lueck, H.-J., Lüftner, D., Marmé, F., Reimer, T., Woeckel, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
7152 POSTER Interim Analysis of a Non-interventional Study of Everolimus After Failure of the First Anti-VEGF Therapy
Bergmann, L, Kube, U, Kindler, M, Goebell, R.J, Jakob, A, Steiner, T, Staehler, M, Overkamp, F, Guderian, G, Doehn, C
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Abstract OT3-02-01: RIBANNA — Real-world evidence of ribociclib plus aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line therapy for postmenopausal women with HR+, HER2– advanced breast cancer (aBC)
Wöckel, A, Fasching, PA, Guderian, G, Heim, J, Jackisch, C, Lück, H-J, Lüftner, D, Marmé, F, Reimer, T, Decker, T
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
282TiPReal-world effectiveness of ribociclib + aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: The RIBANNA study
Fasching, P A, Decker, T, Guderian, G, Heim, J, Jackisch, C, Lueck, H-J, Lüftner, D, Marmé, F, Reimer, T, Woeckel, A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Abstract P6-18-08: Everolimus + exemestane for HR+ advanced breast cancer in routine clinical practice- Final results from the non-interventional trial, BRAWO
Lüftner, D, Schuetz, F, Schneeweiss, A, Grischke, E-M, Bloch, W, Decker, T, Uleer, C, Salat, C, Förster, F, Schmidt, M, Mundhenke, C, Tesch, H, Jackisch, C, Fischer, T, Guderian, G, Hanson, S, Fasching, P
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract OT2-01-18: RIBECCA - A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole
Fasching, PA, Decker, T, Fehm, T, Janni, W, Kuemmel, S, Lueftner, D, Schneeweiss, A, Schuler, M, Guderian, G, Schmidt-Wetzel, S, Reiners, R, Schubert, J, Brucker, S
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Pooled Analysis of Non-Interventional Studies of Everolimus in Patients with Metastatic Renal Cell Carcinoma (MRCC) Refractory to Anti-VEGF Therapy
Bergmann, L., Kube, U., Albiges, L., Eymard, J., Schmidinger, M., Bamias, A., Ktiouet, M., Fischer, G., Xanthaki, D., Guderian, G.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article